A. WB baseline data of BV2 and PMG treated with 10ng/ml LPS for 4 and 8 hours. Cav-1 expression increases while Cav-3 does not. IL-1β (33kDa: IL-1β) response to LPS is attenuated when cells are grown without serum at 8 hours. Blots are normalized to GAPDH. B. Left panels are knockdown control WB for corresponding right panels of knockdown functional consequences following LPS treatment with at least a 50% reduction in expression of caveolin. siRNA treated cells were further analyzed by 10ng/ml LPS treatment and WB for IL-1β response. Both siCav-1 and siCav-3, in either BV2 or PMG, show attenuation of maximal IL-1β expression evident as early as 4 hours. For WT PMG cells, antisense morpholinos (mrpl), specific stable oligos, that bind to complementary sequences, for either mRNA Cav-1 or Cav-3 were designed. VC = DMSO vehicle; SCR = mrpl control; mCav-1 5uM and mCav-3 5uM. Each experiment was repeated n=3 and blots are representative of results. C. A wound healing/migration assay was used to assess BV2 migration following siRNA at 0 min, 8 hours and 24 hours. Plates were fixed, stained with methylene blue and imaged. D. Comparison of oxygen consumption rate (OCR; left panels) and extracellular cellular acidification rate (ECAR; right panels) measurements for BV2 cells treated with siRNAfor gene knockdown of Cav-1 and Cav-3. Scrambled siRNA (SCR)) was used as a control. Comparisons of oxygen consumption rate (OCR; left panel bottom) and extracellular cellular acidification rate (ECAR; right panel bottom) measurements for BV2 cells treated with adenovirus for gene overexpression of Cav-1 and Cav-3. GFP adenoviral vectors were used for controls. (*; p≤ 0.05)